Correlation of Serum Transaminase Levels with Liver Fibrosis Assessed by Transient Elastography in Vietnamese Patients with Nonalcoholic Fatty Liver Disease

References

• Asrani SK, Devarbhavi H, Eaton J, Kamath P. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151–171. PMID: 30266282. doi:10.1016/j.jhep.2018.09.014]
   PubMed Web of Science ®Google Scholar
• Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34(3):274–285. PMID: 21623852. doi:10.1111/j.1365-2036.2011.04724.x]
   PubMed Web of Science ®Google Scholar
• Li H, Wang YJ, Tan K, et al. Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China. Hepatobiliary Pancreat Dis Int. 2009;8(4):377–382. PMID: 19666406.
   PubMed Web of Science ®Google Scholar
• Ulasoglu C, Enc FY, Kaya E, Yilmaz Y. Characterization of patients with biopsy-proven non-alcoholic fatty liver disease and normal aminotransferase levels. J Gastrointestin Liver Dis. 2019;28(4):427–431. PMID: 31826068. doi:10.15403/jgld-293
   PubMed Web of Science ®Google Scholar
• Machado MV, Cortez-Pinto H. Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. J Hepatol. 2013;58(5):1007–1019. PMID: 23183525. doi:10.1016/j.jhep.2012.11.021
   PubMed Web of Science ®Google Scholar
• Prashanth M, Ganesh HK, Vima MV, et al. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. J Assoc Physicians India. 2009;57:205–210. PMID: 19588648.
   PubMedGoogle Scholar
• Amarapurka DN, Amarapurkar AD, Patel ND, et al. Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis. Ann Hepatol. 2006;5(1):30–33. PMID: 16531962. doi:10.1016/S1665-2681(19)32036-8
   PubMedGoogle Scholar
• Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846–854. PMID: 17393509. doi:10.1002/hep.21496
   PubMed Web of Science ®Google Scholar
• Ma X, Liu S, Dong M, Wang Y, Wang M, Xin Y. Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis. BMC Gastroenterol. 2020;20(1):10. PMID: 31937252. doi:10.1186/s12876-020-1165-z
   PubMed Web of Science ®Google Scholar
• Mofrad P, Contos MJ, Haque M, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology. 2003;37(6):1286–1292. PMID: 12774006. doi:10.1053/jhep.2003.50229
   PubMed Web of Science ®Google Scholar
• Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137(1):1–10. PMID: 12093239. doi:10.7326/0003-4819-137-1-200207020-00006
   PubMed Web of Science ®Google Scholar
• Zeng MD, Fan JG, Lu LG, et al. Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. J Dig Dis. 2008;9(2):108–112. PMID: 18419645. doi:10.1111/j.1751-2980.2008.00331.x
   PubMed Web of Science ®Google Scholar
• Wong VW, Vergniol J, Wong GL, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2010;51(2):454–462. PMID: 20101745. doi:10.1002/hep.23312
   PubMed Web of Science ®Google Scholar
• Lupsor M, Badea R, Stefanescu H, et al. Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis. J Gastrointestin Liver Dis. 2010;19(1):53–60. PMID: 20361076.
   PubMed Web of Science ®Google Scholar
• Kumar R, Rastogi A, Sharma MK, et al. Liver stiffness measurements in patients with different stages of nonalcoholic fatty liver disease: diagnostic performance and clinicopathological correlation. Dig Dis Sci. 2013;58(1):265–274. PMID: 22790906. doi:10.1007/s10620-012-2306-1]
   PubMed Web of Science ®Google Scholar
• Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American college of gastroenterology, and the American gastroenterological association. Hepatology. 2012;55(6):2005–2023. PMID: 22488764. doi:10.1002/hep.25762
   PubMed Web of Science ®Google Scholar
• Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013;58(3):593–608. PMID: 23419824. doi:10.1016/j.jhep.2012.12.005
   PubMed Web of Science ®Google Scholar
• Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999;29(3):664–669. PMID: 10051466. doi:10.1002/hep.510290347]
   PubMed Web of Science ®Google Scholar
• Armstrong MJ, Houlihan DD, Bentham L, et al. Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort. J Hepatol. 2012;56(1):234–240. PMID: 21703178. doi:10.1016/j.jhep.2011.03.020]
   PubMed Web of Science ®Google Scholar
• Rej R. Aspartate aminotransferase activity and isoenzyme proportions in human liver tissues. Clin Chem. 1978;24(11):1971–1979. PMID: 213206. doi:10.1093/clinchem/24.11.1971
   PubMed Web of Science ®Google Scholar
• Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med. 2000;342(17):1266–1271. PMID: 10781624. doi:10.1056/NEJM200004273421707
   PubMed Web of Science ®Google Scholar
• Fracanzani AL, Valenti L, Bugianesi E, et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology. 2008;48(3):792–798. PMID: 18752331. doi:10.1002/hep.22429
   PubMed Web of Science ®Google Scholar
• Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011;43(8):617–649. PMID: 21039302. doi:10.3109/07853890.2010.518623
   PubMed Web of Science ®Google Scholar
• Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology. 2003;124(1):71–79. PMID: 12512031. doi:10.1053/gast.2003.50004
   PubMed Web of Science ®Google Scholar
• Kunde SS, Lazenby AJ, Clements RH, Abrams GA. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women. Hepatology. 2005;42(3):650–656. PMID: 16037946. doi:10.1002/hep.20818
   PubMed Web of Science ®Google Scholar